Abhinav Bassi's Publications

About Abhinav Bassi's Publications

Senior Research Fellow and Head of Project Operations -George Institute India
  • PhD, Faculty of Medicine

  • Polypills for the prevention of cardiovascular disease: a framework for wider use

    Nature Medicine Date published:

  • Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress

    International Journal of Stroke Date published:

  • Cumulative Systolic Blood Pressure Load and Risk of Cardiovascular Outcomes in Patients With Diabetes

    Heart, Lung and Circulation Date published:

  • Limited Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management: Insights From Two Randomised Clinical Trials

    Heart, Lung and Circulation Date published:

  • Facile Solution for Recycling Hazardous Flexible Plastic-Laminated Metal Packaging Waste To Produce Value-Added Metal Alloys

    ACS Sustainable Chemistry & Engineering Date published:

  • Challenges in operationalising clinical trials in India during the COVID-19 pandemic

    The Lancet Global Health Date published:

  • A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)

    Journal of Viral Hepatitis Date published:

  • Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

    Intensive Care Medicine Date published:

  • Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

    JAMA: The Journal of the American Medical Association Date published:

  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    The Lancet Date published:

  • Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

    The Lancet Date published:

  • Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial

    The Lancet Date published:

  • Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

    Trials Date published:

  • Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

    Diabetologia Date published:

  • Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

    Unknown Date published:

  • Halving cardiovascular risk with combined blood pressure and cholesterol lowering - Why are we not there yet?

    International Journal of Cardiology Date published: